Thank you very much for your interest in our products. All prices listed on our website are ex-works, Germany, and may attract customs duties when imported.
You may/will be contacted by the shipping company for additional documentation that may be required by the US Customs for clearance.
We offer you the convenience of buying through a local partner, Peptide Solutions LLC who can import the shipment as well as prepay the customs duties and brokerage on your behalf and provide the convenience of a domestic sale.
Workshop Protein Semi-Synthesis to Study Posttranslational Modifications
Workshop Protein Semi-Synthesis to Study Posttranslational Modifications
Published on 24/03/2023
You missed our workshop featuring Prof. Christian F. W. Becker (University of Vienna)? Any further questions? Please get in contact via info@iris-biotech.de.
Highlights
General Introduction (Dr. Karin Rustler; Project Manager; Iris Biotech)
Expert talk “Protein Semi-Synthesis to Study Posttranslational Modifications” (Prof. Christian F.W. Becker; University of Vienna)
Q&A
Speakers
Dr. Thomas BruckdorferChair (CSO at Iris Biotech)
Prof. Dr. Christian F.W. BeckerSpecial Guest (Professor, Head of the Institute of Biological Chemistry at the University of Vienna and of Vienna Doctoral School in Chemistry)
About our special guest
Christian F.W. Becker studied chemistry at the University of Dortmund, obtaining Diploma in 1998 and PhD in 2001. He became a postdoctoral fellow with Gryphon Therapeutics until 2003 and then started his independent career as a group leader at the Max-Planck Institute in Dortmund. In 2007, he was appointed as Professor for Protein Chemistry at the TU Munich, and in 2011 he became Professor and Head of the Institute of Biological Chemistry at the University of Vienna, and in 2020 founding head of the Vienna Doctoral School in Chemistry (DoSChem). His group develops and uses chemical as well as biochemical means to generate peptides and proteins with otherwise unattainable (posttranslational) modifications to address biomedical and biotechnological challenges.
Dr. Karin RustlerInternal Speaker (Head of Marketing and Sales at Iris Biotech)
Recording
Related post
Argpyrimidine Building Block for SPPS
Argpyrimidine is the result of a Maillard Reaction-like nonenzymatic posttranslational modification. You want to investigate the effect of this change on function and stability? Get the building block!